Excisional biopsy: Difference between revisions
Jump to navigation
Jump to search
(CSV import) |
(CSV import) |
||
| Line 1: | Line 1: | ||
{{Definitions | {{Definitions | ||
|Term=excisional biopsy | |Term=excisional biopsy | ||
|Short definition= | |Short definition=exatecan mesylate (EK-suh-TEE-kan MEH-zih-layt) A cancer drug that is a type of topoisomerase inhibitor. Also called DX-8951f | ||
|Type=Cancer terms | |Type=Cancer terms | ||
|Specialty=Oncology | |Specialty=Oncology | ||
Latest revision as of 05:32, 9 January 2023
| Excisional biopsy | |
|---|---|
| Term | Excisional biopsy |
| Short definition | exatecan mesylate (EK-suh-TEE-kan MEH-zih-layt) A cancer drug that is a type of topoisomerase inhibitor. Also called DX-8951f |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
excisional biopsy - (pronounced) (ek-SIH-zhuh-nul BY-op-see) A surgical procedure in which an incision is made through the skin to remove an entire lump or suspicious area so that it can be examined under a microscope for signs of disease. A small amount of healthy tissue around the abnormal area may also be removed
External links
- Medical encyclopedia article on Excisional biopsy
- Wikipedia's article - Excisional biopsy
This MedicineGPT article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski